Back to News
Market Impact: 0.1
Worldwide Clinical Trials Named Finalist for 2026 SCRS Eagle Award
Source: Business Wire
Healthcare & Biotech
Worldwide Clinical Trials was named a finalist for the 2026 SCRS Eagle Award, which recognizes its partnerships with clinical research sites. The brief announcement reports no financial results or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
- Supernus Pharmaceuticals stock hits 52-week low at 40.5 USD
- Top biotechnology stock pick from Guggenheim
- Liquidia shares surge 25% as settlement ends United Therapeutics litigation
- Needham raises Starling Oncology stock price target on growth outlook
- Why is Olympus stock plunging today?